Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation
Overview
Authors
Affiliations
Study Objective: The goal of this study is to create a predictive, interpretable model of early hospital respiratory failure among emergency department (ED) patients admitted with coronavirus disease 2019 (COVID-19).
Methods: This was an observational, retrospective, cohort study from a 9-ED health system of admitted adult patients with severe acute respiratory syndrome coronavirus 2 (COVID-19) and an oxygen requirement less than or equal to 6 L/min. We sought to predict respiratory failure within 24 hours of admission as defined by oxygen requirement of greater than 10 L/min by low-flow device, high-flow device, noninvasive or invasive ventilation, or death. Predictive models were compared with the Elixhauser Comorbidity Index, quick Sequential [Sepsis-related] Organ Failure Assessment, and the CURB-65 pneumonia severity score.
Results: During the study period, from March 1 to April 27, 2020, 1,792 patients were admitted with COVID-19, 620 (35%) of whom had respiratory failure in the ED. Of the remaining 1,172 admitted patients, 144 (12.3%) met the composite endpoint within the first 24 hours of hospitalization. On the independent test cohort, both a novel bedside scoring system, the quick COVID-19 Severity Index (area under receiver operating characteristic curve mean 0.81 [95% confidence interval {CI} 0.73 to 0.89]), and a machine-learning model, the COVID-19 Severity Index (mean 0.76 [95% CI 0.65 to 0.86]), outperformed the Elixhauser mortality index (mean 0.61 [95% CI 0.51 to 0.70]), CURB-65 (0.50 [95% CI 0.40 to 0.60]), and quick Sequential [Sepsis-related] Organ Failure Assessment (0.59 [95% CI 0.50 to 0.68]). A low quick COVID-19 Severity Index score was associated with a less than 5% risk of respiratory decompensation in the validation cohort.
Conclusion: A significant proportion of admitted COVID-19 patients progress to respiratory failure within 24 hours of admission. These events are accurately predicted with bedside respiratory examination findings within a simple scoring system.
Different Modalities in the Management of Post-COVID-19 Olfactory Dysfunction.
Saleh A, Mohamady A, Sobhey M, Shady E Indian J Otolaryngol Head Neck Surg. 2025; 77(1):417-423.
PMID: 40071020 PMC: 11890883. DOI: 10.1007/s12070-024-05213-6.
Exploring the association between happy hypoxia and Coronavirus disease 2019 in the triage phase.
Kaga M, Sasaki M, Masuda T, Sato H, Ueda T, Hirakawa A Future Sci OA. 2025; 11(1):2458413.
PMID: 39882841 PMC: 11792821. DOI: 10.1080/20565623.2025.2458413.
Margiotta R, Sozio E, Del Ben F, Beltrami A, Cesselli D, Comar M Front Immunol. 2025; 15():1452638.
PMID: 39845955 PMC: 11750771. DOI: 10.3389/fimmu.2024.1452638.
Levin S, Sarani N, Hinson J, Naiman M, Cannon C, Smith A Crit Care Explor. 2025; 7(1):e1194.
PMID: 39791853 PMC: 11729153. DOI: 10.1097/CCE.0000000000001194.
Mounesan L, Gharibzadeh S, Parsaeian M, Gouya M, Eybpoosh S, Hosseini A Med J Islam Repub Iran. 2024; 38:93.
PMID: 39678761 PMC: 11644032. DOI: 10.47176/mjiri.38.93.